Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy/Experiment 22/Signature 1

From BugSigDB
Needs review

Curated date: 2024/11/10

Curator: KateRasheed

Revision editor(s): KateRasheed

Source: Additional file 11: Figure S11

Description: Differentially abundant between the Naive group and RZ (R-Rifampin, Z-Pyrazinamide) treatment group.

Abundance in Group 1: increased abundance in RZ (R-Rifampin, Z-Pyrazinamide)

NCBI Quality ControlLinks
Bacteroides
Blautia
Brenneria
Anaeroplasma
Anaerostipes
Thomasclavelia

Revision editor(s): KateRasheed